Westfield Capital Management CO LP Novartis Ag Transaction History

Westfield Capital Management CO LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $70.5 Million - $78.1 Million	-857,963 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$80.93 - $91.1 $31.9 Million - $36 Million	-394,721 Reduced 31.51%	857,963 $74.9 Million
Q1 2020 May 14, 2020	BUY	$70.67 - $99.01 $11.1 Million - $15.6 Million	157,166 Added 14.35%	1,252,684 $103 Million
Q4 2019 Feb 13, 2020	BUY	$84.35 - $95.37 $92.4 Million - $104 Million	1,095,518 New	1,095,518 $104 Million

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

Stay updated on Westfield Capital Management CO LP with notifications on news.